Hongle Li
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 3
- Co-authors
- Qiming WangSen YangXuan WuJing HanYang LiuFucheng HeJinxiu ShengJinlin Jia
- Journals
- Frontiers in Oncology (4 papers)Journal of Cancer (3 papers)Frontiers in Immunology (2 papers)OncoTargets and Therapy (2 papers)Biomarker Research (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Hongle Li
39 papers receiving 718 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Cancer Research 267
- Oncology 220
- Molecular Biology 421
- Pulmonary and Respiratory Medicine 191
- Gastroenterology 22
Countries citing papers authored by Hongle Li
This map shows the geographic impact of Hongle Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongle Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongle Li more than expected).
Fields of papers citing papers by Hongle Li
This network shows the impact of papers produced by Hongle Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongle Li. The network helps show where Hongle Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongle Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 18 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 40 | |
| 14 | 2022 | 41 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 28 | |
| 17 | 2021 | 15 | |
| 18 | MEK inhibitors for the treatment of non-small cell lung cancer Hit paper breakdown → | 2021 | 218 |
| 19 | 2020 | 9 | |
| 20 | 2020 | 1 |
About Hongle Li
Hongle Li is a scholar working on Cancer Research, Gastroenterology, Applied Microbiology and Biotechnology, Oncology and Metals and Alloys, having authored 44 papers that have together received 724 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers), Circular RNAs in diseases (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), MicroRNA in disease regulation (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Cancer Research (267 citations), Oncology (220 citations), Molecular Biology (421 citations), Pulmonary and Respiratory Medicine (191 citations) and Gastroenterology (22 citations). Hongle Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Qiming Wang, Sen Yang, Xuan Wu, Jing Han, Yang Liu, Fucheng He, Jinxiu Sheng, Jinlin Jia, Chang Wang and Junhu Wan. Their work appears in journals such as Frontiers in Oncology, Journal of Cancer, Frontiers in Immunology, OncoTargets and Therapy and Biomarker Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.